{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:41:11Z","timestamp":1778625671268,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaut.2021.102664","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:10:06Z","timestamp":1621901406000},"page":"102664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Long-term (16\u201326 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-1041","authenticated-orcid":false,"given":"Tadashi","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Okayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102664_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/000348947908800501","article-title":"Autoimmune sensorineural hearing loss","volume":"88","author":"McCabe","year":"1979","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.jaut.2021.102664_bib2","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.290.14.1875","article-title":"Treatment of steroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial","volume":"290","author":"Harris","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jaut.2021.102664_bib3","doi-asserted-by":"crossref","first-page":"544Y8","DOI":"10.1016\/j.semarthrit.2004.07.001","article-title":"Immune-mediated inner ear disease: 10-year experience","volume":"34","author":"Broughton","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102664_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.21179","article-title":"Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study","volume":"53","author":"Matteson","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102664_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00016480600606723","article-title":"Immune-mediated inner ear disease","volume":"126","author":"Bovo","year":"2006","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.jaut.2021.102664_bib6","first-page":"591","article-title":"Autoimmune inner ear disease: clinical and laboratory findings and treatment outcome","volume":"37","author":"Dayal","year":"2008","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jaut.2021.102664_bib7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/rheumatology\/ket009","article-title":"Autoimmune sensorineural hearing loss: the otology-rheumatology interface","volume":"52","author":"Mijovic","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102664_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/lio2.28","article-title":"AAO: autoimmune and autoinflammatory (disease) in otology: what is new in immune-mediated hearing loss","volume":"1","author":"Vambutas","year":"2016","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"10.1016\/j.jaut.2021.102664_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/2058738418808680","article-title":"Autoimmune inner ear disease (AIED): a diagnostic challenge","volume":"32","author":"Ciorba","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jaut.2021.102664_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(03)00077-8","article-title":"Autoimmune sensorineural hearing loss: an immunologic perspective","volume":"138","author":"Solares","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102664_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.0307-7772.2003.00738.x","article-title":"Autoimmune sensorineural hearing loss","volume":"28","author":"Mathews","year":"2003","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.jaut.2021.102664_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1288\/00005537-199005000-00015","article-title":"Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss","volume":"100","author":"Harris","year":"1990","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaut.2021.102664_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.1994.03520080053043","article-title":"Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to steroid treatment","volume":"272","author":"Moscicki","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jaut.2021.102664_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(02)00190-X","article-title":"Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss","volume":"130","author":"Lorenz","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102664_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MAO.0b013e31827d0b8b","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of anti-heat shock protein 70 antibodies for the detection of autoimmune hearing loss","volume":"34","author":"Ianuale","year":"2013","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.jaut.2021.102664_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.semarthrit.2003.10.002","article-title":"Autoimmune sensorineural hearing loss: clinical course and treatment outcome","volume":"34","author":"Loveman","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102664_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/lio2.508","article-title":"Autoimmune inner ear disease: a systematic review of management","volume":"5","author":"Breslin","year":"2020","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"10.1016\/j.jaut.2021.102664_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.mao.0000185081.28598.5c","article-title":"Serial audiometry in a clinical trial of AIED treatment","volume":"26","author":"Niparko","year":"2005","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.jaut.2021.102664_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000351289","article-title":"Autoimmune inner ear disease: a retrospective review of forty-seven patients","volume":"18","author":"Matsuoka","year":"2013","journal-title":"Audiol Neurotol"},{"key":"10.1016\/j.jaut.2021.102664_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MAO.0b013e3181a52773","article-title":"Safety of high-dose steroids for the treatment of autoimmune inner ear disease","volume":"30","author":"Alexander","year":"2009","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.jaut.2021.102664_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1288\/00005537-199408000-00004","article-title":"Methotrexate therapy for autoimmune hearing loss: a preliminary report","volume":"104","author":"Sismanis","year":"1994","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaut.2021.102664_bib22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/014556130108001110","article-title":"Autoimmune inner ear disease: steroid and cytotoxic drug therapy","volume":"80","author":"Lasak","year":"2001","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.jaut.2021.102664_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.21179","article-title":"Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study","volume":"53","author":"Matteson","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102664_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.mao.0000185082.28598.87","article-title":"Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study","volume":"26","author":"Cohen","year":"2005","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.jaut.2021.102664_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1026445108136","article-title":"Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states","volume":"20","author":"Schmid","year":"2000","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jaut.2021.102664_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-2952(99)00090-8","article-title":"Equivalent doses and relative drug potencies for non-genomicglucocorticoid eects: a novel glucocorticoid hierarchy","volume":"58","author":"Buttgereit","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jaut.2021.102664_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2004.10.003","article-title":"Developments in glucocorticoid therapy","volume":"31","author":"Bijlsma","year":"2005","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2021.102664_bib28","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3390\/jcm9092709","article-title":"Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues","volume":"9","author":"Porta","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2021.102664_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2147\/TCRM.S160760","article-title":"Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis","volume":"14","author":"Wu","year":"2018","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.jaut.2021.102664_bib30","first-page":"1","article-title":"Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis","volume":"20","author":"Nakamura","year":"2020","journal-title":"Mod. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112100072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112100072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:36Z","timestamp":1760257716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112100072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"alternative-id":["S089684112100072X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102664","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term (16\u201326 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102664"}}